[go: up one dir, main page]

MXPA05008179A - Procedimiento para la fabricacion de alcaloides de quinazolina. - Google Patents

Procedimiento para la fabricacion de alcaloides de quinazolina.

Info

Publication number
MXPA05008179A
MXPA05008179A MXPA05008179A MXPA05008179A MXPA05008179A MX PA05008179 A MXPA05008179 A MX PA05008179A MX PA05008179 A MXPA05008179 A MX PA05008179A MX PA05008179 A MXPA05008179 A MX PA05008179A MX PA05008179 A MXPA05008179 A MX PA05008179A
Authority
MX
Mexico
Prior art keywords
compound
methods
producing
quinazoline alkaloids
iii
Prior art date
Application number
MXPA05008179A
Other languages
English (en)
Inventor
Joachim Moormann
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32747532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05008179(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of MXPA05008179A publication Critical patent/MXPA05008179A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se refiere a un metodo para la fabricacion de un compuesto de formula (I) haciendo reaccionar un compuesto de formula (II) con 2-pirrolidona, por lo cual se utiliza un excedente de la 2-pirrolidona, con relacion al compuesto (II). la invencion tambien se refiere a un metodo para la fabricacion de un compuesto de formula (III), que comprende las siguientes etapas: (A) fabricacion del compuesto (I); (B) reaccion de reduccion para obtener el compuesto (III) en forma de sal; (C) liberacion del compuesto (III) a partir de la sal (ver formulas (I), (II) y (III)).
MXPA05008179A 2003-02-03 2004-01-22 Procedimiento para la fabricacion de alcaloides de quinazolina. MXPA05008179A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10304141A DE10304141B4 (de) 2003-02-03 2003-02-03 Verfahren zur Herstellung von Chinazolin-Alkaloiden
PCT/EP2004/000485 WO2004069836A1 (de) 2003-02-03 2004-01-22 Verfahren zur herstellung von chinazolin-alkaloiden

Publications (1)

Publication Number Publication Date
MXPA05008179A true MXPA05008179A (es) 2006-02-17

Family

ID=32747532

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008179A MXPA05008179A (es) 2003-02-03 2004-01-22 Procedimiento para la fabricacion de alcaloides de quinazolina.

Country Status (25)

Country Link
US (1) US7495096B2 (es)
EP (1) EP1590351B1 (es)
JP (1) JP2006516578A (es)
KR (1) KR20050096165A (es)
CN (1) CN100558727C (es)
AR (1) AR042946A1 (es)
AT (1) ATE407135T1 (es)
AU (1) AU2004208873B2 (es)
BR (1) BRPI0407012A (es)
CA (1) CA2514945A1 (es)
DE (2) DE10304141B4 (es)
DK (1) DK1590351T3 (es)
EA (1) EA009047B1 (es)
ES (1) ES2314366T3 (es)
MX (1) MXPA05008179A (es)
MY (1) MY141734A (es)
NO (1) NO20053689L (es)
NZ (1) NZ541101A (es)
PL (1) PL378406A1 (es)
PT (1) PT1590351E (es)
SI (1) SI1590351T1 (es)
TW (1) TW200418811A (es)
UA (1) UA81287C2 (es)
WO (1) WO2004069836A1 (es)
ZA (1) ZA200505160B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004048927A1 (de) * 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
JP7498108B2 (ja) 2017-08-03 2024-06-11 ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニー 医学的障害の予防および治療のための化合物およびその使用
KR102728780B1 (ko) * 2021-11-30 2024-11-08 이화여자대학교 산학협력단 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
JP3180464B2 (ja) * 1991-08-30 2001-06-25 新日本理化株式会社 ジアセタール化合物の製造方法
DE19530606A1 (de) * 1995-08-21 1997-02-27 Basf Ag 1-(Pyridyl)-pyrazole
JP3958452B2 (ja) * 1997-10-31 2007-08-15 大日精化工業株式会社 新規化学発光試薬及びその製造方法
DE19906975B4 (de) 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Also Published As

Publication number Publication date
AU2004208873A1 (en) 2004-08-19
PL378406A1 (pl) 2006-04-03
DE10304141A1 (de) 2004-08-26
CA2514945A1 (en) 2004-08-19
ES2314366T3 (es) 2009-03-16
KR20050096165A (ko) 2005-10-05
EP1590351B1 (de) 2008-09-03
AU2004208873B2 (en) 2009-12-17
PT1590351E (pt) 2008-11-21
WO2004069836A1 (de) 2004-08-19
EA200501135A1 (ru) 2006-02-24
TW200418811A (en) 2004-10-01
DE502004007980D1 (de) 2008-10-16
DE10304141B4 (de) 2006-03-09
US7495096B2 (en) 2009-02-24
NO20053689L (no) 2005-07-29
NZ541101A (en) 2009-03-31
SI1590351T1 (sl) 2009-02-28
AR042946A1 (es) 2005-07-06
UA81287C2 (en) 2007-12-25
CN1745084A (zh) 2006-03-08
ATE407135T1 (de) 2008-09-15
MY141734A (en) 2010-06-15
CN100558727C (zh) 2009-11-11
JP2006516578A (ja) 2006-07-06
DK1590351T3 (da) 2008-12-15
EP1590351A1 (de) 2005-11-02
HK1075898A1 (zh) 2005-12-30
BRPI0407012A (pt) 2006-01-10
ZA200505160B (en) 2007-01-31
US20060084669A1 (en) 2006-04-20
EA009047B1 (ru) 2007-10-26

Similar Documents

Publication Publication Date Title
WO2006004100A8 (ja) 1,2-ジヒドロピリジン-2-オン化合物の製造方法
RU2010126906A (ru) Способ получения производного индолинона
MY147440A (en) Process for making 3-substituted 2-amino-5-halobenzamides
MX2009003698A (es) Preparacion de azoxistrobina.
MX2009001816A (es) Procedimiento para la produccion de acido d,l-2-hidroxi-4-alquilti o butirico.
UA83910C2 (ru) Способ получения 5-гидрокси-4-тиометилпиразольного соединения
TNSN07403A1 (en) Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
WO2006067456A3 (en) Process for preparing rosuvastatin
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
WO2009066735A1 (ja) 2-アザアダマンタン類の製造方法
YU101103A (en) Technical synthesis method for producing tropenol
HU0001618D0 (en) Process for producing a known tetrazole derivative
MXPA05008179A (es) Procedimiento para la fabricacion de alcaloides de quinazolina.
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
GB0417063D0 (en) Process for the preparation of optically-active compounds
MEP1708A (xx) Postupak proizvodnje thip-a
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
EP2189450A4 (en) PROCESS FOR THE PREPARATION OF A CHINAZOLINE DERIVATIVE
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
WO2005108408A3 (en) Process for the racemoselective preparation of ansa-metallocenes
TW200624435A (en) Process for preparing iridium(Ⅲ) ketoketonates
DE50309092D1 (de) Verfahren zur herstellung von palladium(0)-haltigen verbindungen
MXPA05003881A (es) Preparacion de compuestos triazospiro.
IL178062A0 (en) Process for preparing cyclohexanediacetic acid monoamide

Legal Events

Date Code Title Description
FG Grant or registration